| US 7,465,800 B2 | ||
| Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione | ||
| Markian S. Jaworsky, Hopewell, N.J. (US); Roger Shen-Chu Chen, Edison, N.J. (US); and George W. Muller, Bridgewater, N.J. (US) | ||
| Assigned to Celgene Corporation, Summit, N.J. (US) | ||
| Filed on Sep. 03, 2004, as Appl. No. 10/934,863. | ||
| Claims priority of provisional application 60/499723, filed on Sep. 04, 2003. | ||
| Prior Publication US 2005/0096351 A1, May 05, 2005 | ||
| Int. Cl. C07D 401/04 (2006.01) | ||
| U.S. Cl. 546—200 [514/323] | 14 Claims |

| 1. Crystalline 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione hemihydrate. |